Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8370224 | 1.00 | KIF11 (0.49) | KIF11DNMT1 | |
| SCHEMBL21084958 | 1.00 | KIF11 (0.49) | KIF11DNMT1 | |
| SCHEMBL20202843 | 0.91 | KIF11 (0.48) | KIF11DNMT1 | |
| SCHEMBL20202835 | 0.88 | MMP13 (0.44) | KIF11DNMT1 | |
| SCHEMBL2818358 | 0.88 | KIF11 (0.43) | KIF11DNMT1 | |
| SCHEMBL2818361 | 0.88 | KIF11 (0.43) | KIF11DNMT1 | |
| SCHEMBL8416048 | 0.87 | KIF11 (0.42) | KIF11DNMT1 | |
| SCHEMBL24360323 | 0.85 | KIF11 (0.47) | KIF11DNMT1 | |
| SCHEMBL24360324 | 0.85 | KIF11 (0.47) | KIF11DNMT1 | |
| SCHEMBL24360331 | 0.84 | KIF11 (0.46) | KIF11DNMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PEPTIDREAM INC (JP) | 2026-01-15 | — | — | US | disclosed |
| EP-4534524-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PeptiDream Inc. (JP) | 2025-04-09 | — | — | EP | disclosed |
| CN-118178369-A | Application of aminothiol compound as cerebral nerve or heart protecting agent | 上海科州药物研发有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-114072381-B | Application of aminothiol compound as cerebral nerve or heart protecting agent | 上海科州药物研发有限公司 | 2024-02-27 | — | — | CN | disclosed |
| EP-3508476-B1 | AMINO MERCAPTAN COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF IN PROTECTION AGAINST RADIATION | SHANGHAI KECHOW PHARMA INC (CN) | 2023-11-22 | — | — | EP | disclosed |
| US-20220259164-A1 | USE OF AMINOTHIOL COMPOUNDS AS CEREBRAL NERVE OR HEART PROTECTIVE AGENT | SHANGHAI KECHOW PHARMA, INC. (CN) | 2022-08-18 | — | — | US | disclosed |
| EP-3984993-A1 | USE OF AMINOTHIOL COMPOUNDS AS CEREBRAL NERVE OR HEART PROTECTIVE AGENT | Shanghai Kechow Pharma, Inc. (CN) | 2022-04-20 | — | — | EP | disclosed |
| CN-112480122-B | Tetrahydroimidazo [1,2-a ] pyrazine compound, composition, preparation method and application thereof | 中山大学 | 2022-03-22 | — | — | CN | disclosed |
| CN-114072381-A | Use of aminothiol compounds as neurocerebroprotective or cardioprotective agents | 上海科州药物研发有限公司 | 2022-02-18 | — | — | CN | disclosed |
| CN-110167915-B | Amino-thiol compound, preparation method thereof and application thereof in radiation protection | 上海科州药物研发有限公司 | 2021-11-26 | — | — | CN | disclosed |
| US-11008286-B2 | Amino mercaptan compound and preparation method therefor and use thereof in protection against radiation | SHANGHAI KECHOW PHARMA, INC (CN) | 2021-05-18 | — | — | US | disclosed |
| CN-112480122-A | Tetrahydroimidazo [1,2-a ] pyrazine compound, composition, preparation method and application thereof | 中山大学 | 2021-03-12 | — | — | CN | disclosed |
| WO-2020249120-A1 | USE OF AMINOTHIOL COMPOUNDS AS CEREBRAL NERVE OR HEART PROTECTIVE AGENT | 上海科州药物研发有限公司 | 2020-12-17 | — | — | WO | disclosed |
| US-10413583-B2 | Synthetic substrates for enzymes that catalyze reactions of modified cysteines and related methods | THE UNIVERSITY OF CHICAGO (US) | 2019-09-17 | — | — | US | disclosed |
| EP-3508476-A1 | AMINO MERCAPTAN COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF IN PROTECTION AGAINST RADIATION | Inst Of Radiation Medicine Chinese Acad Of Medical Sciences (CN) | 2019-07-10 | — | — | EP | disclosed |
| US-20190202779-A1 | AMINO MERCAPTAN COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF IN PROTECTION AGAINST RADIATION | SHANGHAI KECHOW PHARMA, INC. (CN) | 2019-07-04 | — | — | US | disclosed |
| US-20180147250-A1 | SYNTHETIC SUBSTRATES FOR ENZYMES THAT CATALYZE REACTIONS OF MODIFIED CYSTEINES AND RELATED METHODS | THE UNIVERSITY OF CHICAGO | 2018-05-31 | — | — | US | disclosed |
| US-20180147250-A1 | SYNTHETIC SUBSTRATES FOR ENZYMES THAT CATALYZE REACTIONS OF MODIFIED CYSTEINES AND RELATED METHODS | THE UNIVERSITY OF CHICAGO | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190202779-A1 | AMINO MERCAPTAN COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF IN PROTECTION AGAINST RADIATION | MGMT, PRMT8, SULT1A1 | KIF11 4017/4885DNMT1 1552/4885 |
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | NSUN3, BCAT1, SLC43A1 | KIF11 3394/4885DNMT1 1890/4885 |
| US-11008286-B2 | Amino mercaptan compound and preparation method therefor and use thereof in protection against radiation | MGMT, GSTA1, PRMT1 | KIF11 3193/4885DNMT1 1065/4885 |
| US-10413583-B2 | Synthetic substrates for enzymes that catalyze reactions of modified cysteines and related methods | DNPEP, PTMS, CTH | KIF11 4826/4885DNMT1 2205/4885 |
| US-20180147250-A1 | SYNTHETIC SUBSTRATES FOR ENZYMES THAT CATALYZE REACTIONS OF MODIFIED CYSTEINES AND RELATED METHODS | DNPEP, PTMS, CTH | KIF11 4826/4885DNMT1 2205/4885 |
| US-20220259164-A1 | USE OF AMINOTHIOL COMPOUNDS AS CEREBRAL NERVE OR HEART PROTECTIVE AGENT | TNNI3, TNNT2, AADAT | KIF11 4607/4885DNMT1 3803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.